Efficacy of clofarabine and low-dose cytarabine combination for genetically high-risk acute myeloid leukemia prior to allogeneic stem cell transplantation.

Carlos Enrique Vigil,Nusrat Jahan,Oana Valeria Paun,Jennifer Weis,Kevin Heckman,Margarida Magalhaes-Silverman,Thomas H. Carter

Efficacy of clofarabine and low-dose cytarabine combination for genetically high-risk acute myeloid leukemia prior to allogeneic stem cell transplantation.

2017

Carlos Enrique Vigil
Nusrat Jahan
Oana Valeria Paun
Jennifer Weis
Kevin Heckman
Margarida Magalhaes-Silverman
Thomas H. Carter

e18515Background: The outcome of genetically high risk acute myeloid leukemia (AML) patients (pts) remains poor, with a median overall survival (OS) of a few months after the failure of regimens. L...

Keywords:

Stem cell
Oncology
Clofarabine
Myeloid leukemia
Pathology
Transplantation
Cytarabine
Medicine
Internal medicine
low dose cytarabine
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations